SCHEMBL21663301

SCHEMBL21663301

Cc1nc2c(n1C1CCCC1)-c1nc(N)ncc1C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ STAT3 P40763 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.37
▸ MAPT P10636 1/20 0.37
▸ GFER P55789 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ CDK9 P50750 3/20 0.37
▸ DYRK1A Q13627 2/20 0.37
▸ DYRK2 Q92630 2/20 0.37
▸ GAA P10253 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ CCNT1 O60563 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21663152 0.95 CDK9 (0.34) ALDH1A1CYP2D6MEN1CYP1A2CYP3A4
SCHEMBL21662994 0.76 CDK4 (0.40) ALDH1A1CYP2D6KDM4EDRD3DRD2
SCHEMBL21663305 0.75 CDK4 (0.48) ALDH1A1MEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL21663312 0.71 DRD3 (0.34) ALDH1A1CYP2D6KDM4EMAPTDRD3
SCHEMBL1448068 0.68 CYP11B2 (0.34) ALDH1A1KDM4EMAPTGFERTDP1
SCHEMBL21663174 0.68 CDK4 (0.35) ALDH1A1CYP2D6KDM4EDRD3DRD2
SCHEMBL4246503 0.68 ALDH1A1 (0.38) ALDH1A1CYP2D6MEN1CYP1A2CYP3A4
SCHEMBL21663147 0.67 CDK4 (0.53) ALDH1A1SMN1; SMN2KDM4EMAPTAURKA
SCHEMBL22612188 0.66 KDM4E (0.44) ALDH1A1SMN1; SMN2KDM4EMAPTPIK3CD
SCHEMBL18288760 0.65 CDK4 (0.55) CDK9CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11168088-B2 Pyridylamino substituted heterotricyclic compounds, and preparation method and pharmaceutical use thereof SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. 2021-11-09 — — US disclosed
US-20200039983-A1 PYRIDYLAMINO SUBSTITUTED HETEROTRICYCLIC COMPOUNDS, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2020-02-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11168088-B2 Pyridylamino substituted heterotricyclic compounds, and preparation method and pharmaceutical use thereof CYP2D6, PNPO, CYP2B6 ALDH1A1 2155/4885CYP2D6 1/4885MEN1 728/4885
US-20200039983-A1 PYRIDYLAMINO SUBSTITUTED HETEROTRICYCLIC COMPOUNDS, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF CYP2D6, PNPO, CYP2B6 ALDH1A1 2155/4885CYP2D6 1/4885MEN1 728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback